ConductScience.org, home

Paper113803

Zimelidine: a therapeutic and pharmacokinetic study in depression.

Coppen A and 3 others. Psychopharmacology (Berl), 1979. Cited by 132 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. Zimelidine: a therapeutic and pharmacokinetic study in depression. Papers, record 113803. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/113803

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Zimelidine: a therapeutic and pharmacokinetic study in depression.
PubMed
Journal
Psychopharmacology (Berl)
PubMed
Year
1979
PubMed
Publication types
Clinical Trial, Comparative Study, Controlled Clinical Trial, Journal Article, Randomized Controlled Trial
PubMed
Citations, by iCite
132
iCite
Relative citation ratio, by iCite
8.29
iCite
Revised in PubMed
2019-07-26
PubMed

Authors4

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Coppen AA
2Ramo Rao VAV A
3Swade CC
4Wood KK

Source PubMed

Topics15

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Antidepressive AgentsMajor topic
DepressionMajor topic
PyridinesMajor topic
Allylamine
Amitriptyline
Body Weight
Bridged Bicyclo Compounds
Double-Blind Method
Evaluation Studies as Topic
Female
Humans
Kinetics
Male
Middle Aged
Psychiatric Status Rating Scales

Source PubMed

References10

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
1834,363Inhibition of the neuronal uptake of 5-hydroxytryptamine and noradrenaline in rat brain by (Z)- and (E)-3-(4-bromophenyl)-N,N-dimethyl-3-(3-pyridyl) allylamines and their secondary analogues.Neuropharmacology1977https://conductscience.org/library/papers/834363PubMed
2341,907Effect of zimelidine (H 102/09) in depressive patients.Arzneimittelforschung1977https://conductscience.org/library/papers/341907PubMed
3321,228Antidepressant evaluation and the pharmacological actions of FG4963 in depressive patients.Eur J Pharmacol1977https://conductscience.org/library/papers/321228PubMed
414,257,398CLINICAL TRIAL OF THE TREATMENT OF DEPRESSIVE ILLNESS. REPORT TO THE MEDICAL RESEARCH COUNCIL BY ITS CLINICAL PSYCHIATRY COMMITTEE.Br Med J1965https://conductscience.org/library/papers/14257398PubMed
5947,293(Z)-dimethylamino-1-(4-bromophenyl)-1-(3-pyridyl) propene (h 102/09), a new selective inhibitor of the neuronal 5-hydroxytryptamine uptake.Acta Pharmacol Toxicol (Copenh)1976https://conductscience.org/library/papers/947293PubMed
6837,638Initial clinical trial based on biochemical methodology of zimelidine (a serotonin uptake inhibitor) in depressed patients.Clin Pharmacol Ther1977https://conductscience.org/library/papers/837638PubMed
774,566Amitriptyline plasma-concentration and clinical effect. A World Health Organisation Collaborative Study.Lancet1978https://conductscience.org/library/papers/74566PubMed
8603,822Lithium salts: therapeutic and unwanted effects.Br J Hosp Med1977https://conductscience.org/library/papers/603822PubMed
9668,137Platelet 5-hydroxytryptamine accumulation in depressive illness.Clin Chim Acta1978https://conductscience.org/library/papers/668137PubMed
1014,399,272A rating scale for depression.J Neurol Neurosurg Psychiatry1960https://conductscience.org/library/papers/14399272PubMed

Cited by31

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 132 citations.

PMIDTitleJournalYearIn PapersSource
35,634,269Enzymatic N-Allylation of Primary and Secondary Amines Using Renewable Cinnamic Acids Enabled by Bacterial Reductive Aminases.ACS Sustain Chem Eng2022https://conductscience.org/library/papers/35634269PubMed
9,295,172In vivo electrochemical measurements of serotonin clearance in rat striatum: effects of neonatal 6-hydroxydopamine-induced serotonin hyperinnervation and serotonin uptake inhibitors.J Neural Transm (Vienna)1997https://conductscience.org/library/papers/9295172PubMed
7,420,073Antidepressant drugs and ethanol: behavioral and pharmacokinetic interactions in mice.J Neural Transm1980https://conductscience.org/library/papers/7420073PubMed
7,002,182Measurement of serum drug levels in the assessment of antidepressants.Br J Clin Pharmacol1980https://conductscience.org/library/papers/7002182PubMed
6,768,073Inhibition of 5-hydroxytryptamine uptake in human platelets by antidepressant agents in vivo.Psychopharmacology (Berl)1980https://conductscience.org/library/papers/6768073PubMed
6,457,309Effects of zimelidine and desipramine on serotonin and noradrenaline uptake mechanisms in relation to plasma concentrations and to therapeutic effects during treatment of depression.Psychopharmacology (Berl)1981https://conductscience.org/library/papers/6457309PubMed
6,452,151Effect of zimelidine, a new antidepressant, on appetite and body weight.Br J Clin Pharmacol1981https://conductscience.org/library/papers/6452151PubMed
6,450,427Plasma levels of zimelidine and norzimelidine in endogenous depression.Psychopharmacology (Berl)1980https://conductscience.org/library/papers/6450427PubMed
6,448,650Event recording in a clinical trial of a new medicine.Br Med J1980https://conductscience.org/library/papers/6448650PubMed
6,445,274Pharmacokinetics of zimelidine. Systemic availability of zimelidine and norzimelidine in human volunteers.Eur J Clin Pharmacol1980https://conductscience.org/library/papers/6445274PubMed
6,438,684Effects of the two antidepressant drugs mianserin and indalpine on the serotonergic system: single-cell studies in the rat.Psychopharmacology (Berl)1984https://conductscience.org/library/papers/6438684PubMed
6,429,698Biochemical effects and drug levels in rats after long-term treatment with the specific 5-HT-uptake inhibitor, citalopram.Psychopharmacology (Berl)1984https://conductscience.org/library/papers/6429698PubMed
6,402,001Biological classification of depressive illness.Br J Clin Pharmacol1983https://conductscience.org/library/papers/6402001PubMed
6,306,711Effect of serotonin uptake inhibition by zimelidine on hypothalamic-pituitary-adrenal activity.Psychopharmacology (Berl)1983https://conductscience.org/library/papers/6306711PubMed
6,238,829Effects of zimeldine, mianserin and amitriptyline on psychomotor skills and their interaction with ethanol a placebo controlled cross-over study.Eur J Clin Pharmacol1984https://conductscience.org/library/papers/6238829PubMed
6,228,368Pharmacokinetic study of zimelidine using a new GLC method.Clin Pharmacokinet1983https://conductscience.org/library/papers/6228368PubMed
6,227,367Safety of zimeldine in overdose.Br Med J (Clin Res Ed)1983https://conductscience.org/library/papers/6227367PubMed
6,226,335Possible hepatotoxicity of zimelidine.Br Med J (Clin Res Ed)1983https://conductscience.org/library/papers/6226335PubMed
6,215,240Zimelidine: a review of its pharmacological properties and therapeutic efficacy in depressive illness.Drugs1982https://conductscience.org/library/papers/6215240PubMed
6,215,083Severe headache and disturbed liver function during treatment with zimelidine.Br Med J (Clin Res Ed)1982https://conductscience.org/library/papers/6215083PubMed

See all 31 cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/113803

GET https://conductscience.org/api/papers/v1/113803/cited_by?page=2